Concepts (236)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Viral Matrix Proteins | 5 | 2018 | 1243 | 1.40 | Why? |
| Virus Release | 2 | 2018 | 253 | 1.26 | Why? |
| Vaccines, Attenuated | 2 | 2017 | 952 | 0.92 | Why? |
| Virus Assembly | 2 | 2018 | 438 | 0.73 | Why? |
| Virology | 1 | 2021 | 489 | 0.65 | Why? |
| Influenza A Virus, H3N2 Subtype | 2 | 2018 | 572 | 0.65 | Why? |
| Epithelial Cells | 3 | 2018 | 3508 | 0.59 | Why? |
| Madin Darby Canine Kidney Cells | 3 | 2018 | 640 | 0.45 | Why? |
| Golgi Apparatus | 3 | 2008 | 178 | 0.44 | Why? |
| Nose | 1 | 2017 | 1093 | 0.44 | Why? |
| Viral Proteins | 6 | 2008 | 7370 | 0.40 | Why? |
| Nasal Mucosa | 1 | 2017 | 1218 | 0.40 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.38 | Why? |
| Cell Membrane | 2 | 2018 | 743 | 0.38 | Why? |
| Influenza A virus | 2 | 2017 | 2234 | 0.37 | Why? |
| SARS Virus | 8 | 2008 | 13021 | 0.37 | Why? |
| Curriculum | 1 | 2021 | 3083 | 0.34 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2018 | 2984 | 0.33 | Why? |
| Dogs | 3 | 2018 | 2529 | 0.31 | Why? |
| Influenza Vaccines | 2 | 2017 | 2941 | 0.27 | Why? |
| Endoplasmic Reticulum | 3 | 2018 | 430 | 0.22 | Why? |
| Convalescence | 3 | 2021 | 2829 | 0.22 | Why? |
| Iodine Radioisotopes | 1 | 2021 | 124 | 0.22 | Why? |
| Antibodies, Viral | 14 | 2021 | 51949 | 0.21 | Why? |
| Acetamides | 1 | 2021 | 141 | 0.20 | Why? |
| Education, Graduate | 1 | 2021 | 118 | 0.20 | Why? |
| Virus Replication | 2 | 2017 | 14331 | 0.19 | Why? |
| Tropism | 1 | 2020 | 210 | 0.19 | Why? |
| Amphiregulin | 1 | 2018 | 38 | 0.19 | Why? |
| Immunity, Innate | 1 | 2017 | 6570 | 0.19 | Why? |
| Apoptosis | 2 | 2021 | 2335 | 0.19 | Why? |
| Suppression, Genetic | 1 | 2017 | 15 | 0.19 | Why? |
| Influenza, Human | 3 | 2017 | 10779 | 0.18 | Why? |
| Primates | 1 | 2021 | 584 | 0.18 | Why? |
| Vero Cells | 10 | 2021 | 14117 | 0.18 | Why? |
| Virion | 1 | 2006 | 1444 | 0.18 | Why? |
| Influenzavirus C | 1 | 2017 | 37 | 0.18 | Why? |
| Cytoplasm | 2 | 2017 | 304 | 0.17 | Why? |
| DNA Replication | 1 | 2017 | 121 | 0.17 | Why? |
| Animals | 17 | 2021 | 78931 | 0.17 | Why? |
| Cricetinae | 4 | 2021 | 3344 | 0.17 | Why? |
| Cell Line | 4 | 2021 | 12040 | 0.16 | Why? |
| Antigen-Presenting Cells | 1 | 2017 | 206 | 0.16 | Why? |
| Mesocricetus | 3 | 2021 | 1847 | 0.16 | Why? |
| Genetic Loci | 1 | 2017 | 439 | 0.15 | Why? |
| Positron-Emission Tomography | 1 | 2021 | 802 | 0.15 | Why? |
| Interleukin-1beta | 1 | 2021 | 992 | 0.15 | Why? |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 526 | 0.15 | Why? |
| Membrane Proteins | 3 | 2021 | 1733 | 0.15 | Why? |
| Antibody Affinity | 1 | 2020 | 1078 | 0.15 | Why? |
| Models, Immunological | 1 | 2021 | 727 | 0.15 | Why? |
| Receptors, Antigen, T-Cell | 1 | 2021 | 760 | 0.15 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2020 | 584 | 0.14 | Why? |
| Blood Donors | 4 | 2021 | 2956 | 0.14 | Why? |
| Open Reading Frames | 3 | 2007 | 1898 | 0.14 | Why? |
| HEK293 Cells | 2 | 2018 | 8394 | 0.14 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2008 | 12361 | 0.13 | Why? |
| Disease Models, Animal | 3 | 2021 | 10998 | 0.13 | Why? |
| Neurons | 1 | 2020 | 864 | 0.13 | Why? |
| Reverse Genetics | 1 | 2017 | 439 | 0.13 | Why? |
| Pyrimidines | 1 | 2021 | 1557 | 0.13 | Why? |
| Molecular Sequence Data | 3 | 2008 | 3198 | 0.13 | Why? |
| Immunologic Memory | 2 | 2021 | 3362 | 0.12 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3633 | 0.12 | Why? |
| Real-Time Polymerase Chain Reaction | 3 | 2021 | 11367 | 0.12 | Why? |
| Teaching | 1 | 2021 | 1208 | 0.12 | Why? |
| ABO Blood-Group System | 1 | 2021 | 995 | 0.11 | Why? |
| Immunocompromised Host | 1 | 2008 | 5150 | 0.11 | Why? |
| Orthomyxoviridae Infections | 1 | 2018 | 1001 | 0.11 | Why? |
| Pyrazoles | 1 | 2021 | 1791 | 0.11 | Why? |
| Antibodies, Neutralizing | 7 | 2021 | 25288 | 0.11 | Why? |
| Cells, Cultured | 3 | 2018 | 5835 | 0.11 | Why? |
| Immune Evasion | 1 | 2021 | 2081 | 0.10 | Why? |
| Sex Characteristics | 1 | 2018 | 1120 | 0.10 | Why? |
| Antigens, Viral | 3 | 2021 | 6298 | 0.10 | Why? |
| Microscopy, Confocal | 3 | 2006 | 343 | 0.10 | Why? |
| Sensitivity and Specificity | 5 | 2021 | 22971 | 0.10 | Why? |
| Epitopes, T-Lymphocyte | 1 | 2021 | 2262 | 0.10 | Why? |
| Diagnostic Tests, Routine | 1 | 2021 | 2643 | 0.10 | Why? |
| Pregnancy Complications | 1 | 2021 | 1388 | 0.10 | Why? |
| Immunity | 1 | 2021 | 2651 | 0.10 | Why? |
| Humans | 34 | 2021 | 930598 | 0.09 | Why? |
| In Situ Nick-End Labeling | 1 | 2007 | 39 | 0.09 | Why? |
| Guidelines as Topic | 1 | 2021 | 2844 | 0.09 | Why? |
| Cell Line, Transformed | 1 | 2007 | 87 | 0.09 | Why? |
| Leukocytes, Mononuclear | 1 | 2017 | 2115 | 0.09 | Why? |
| Immunization, Passive | 5 | 2021 | 10067 | 0.09 | Why? |
| Saliva | 2 | 2021 | 4679 | 0.09 | Why? |
| Amino Acid Sequence | 3 | 2008 | 6049 | 0.08 | Why? |
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 393 | 0.08 | Why? |
| Viruses | 1 | 2020 | 2238 | 0.08 | Why? |
| CD4 Antigens | 1 | 2008 | 306 | 0.08 | Why? |
| Amino Acid Motifs | 2 | 2006 | 620 | 0.08 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.08 | Why? |
| Gene Deletion | 1 | 2008 | 430 | 0.08 | Why? |
| Cyclophosphamide | 1 | 2008 | 387 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.08 | Why? |
| Protein Structure, Tertiary | 2 | 2008 | 1565 | 0.08 | Why? |
| Antibody Specificity | 2 | 2021 | 1328 | 0.08 | Why? |
| B-Lymphocytes | 1 | 2021 | 4418 | 0.08 | Why? |
| Transfection | 2 | 2006 | 864 | 0.08 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.08 | Why? |
| Universities | 1 | 2021 | 4374 | 0.08 | Why? |
| Sequence Homology, Amino Acid | 1 | 2008 | 945 | 0.07 | Why? |
| Biological Transport | 1 | 2006 | 290 | 0.07 | Why? |
| Myocarditis | 1 | 2021 | 2731 | 0.07 | Why? |
| T-Lymphocytes | 2 | 2021 | 6670 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| Mutagenesis | 1 | 2006 | 394 | 0.06 | Why? |
| Nucleocapsid Proteins | 2 | 2006 | 3120 | 0.06 | Why? |
| Antibody Formation | 3 | 2021 | 4038 | 0.06 | Why? |
| Sequence Deletion | 1 | 2007 | 674 | 0.06 | Why? |
| Virus Diseases | 1 | 2020 | 3779 | 0.06 | Why? |
| Students | 1 | 2021 | 5255 | 0.06 | Why? |
| Nasal Cavity | 1 | 2008 | 909 | 0.06 | Why? |
| Genome, Viral | 3 | 2021 | 13157 | 0.06 | Why? |
| Weight Loss | 1 | 2008 | 826 | 0.06 | Why? |
| Hemagglutination | 1 | 2021 | 36 | 0.06 | Why? |
| Voltage-Dependent Anion Channel 1 | 1 | 2021 | 28 | 0.06 | Why? |
| Biophysical Phenomena | 1 | 2021 | 78 | 0.06 | Why? |
| Arabidopsis Proteins | 1 | 2021 | 54 | 0.06 | Why? |
| Lung | 4 | 2021 | 31049 | 0.05 | Why? |
| Oligonucleotide Probes | 1 | 2021 | 88 | 0.05 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.05 | Why? |
| Immunoglobulin Class Switching | 1 | 2021 | 133 | 0.05 | Why? |
| Hemagglutination Tests | 1 | 2021 | 124 | 0.05 | Why? |
| Jurkat Cells | 1 | 2021 | 273 | 0.05 | Why? |
| Investigational New Drug Application | 1 | 2020 | 75 | 0.05 | Why? |
| Caspases | 1 | 2021 | 156 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| RNA, Viral | 5 | 2021 | 32276 | 0.05 | Why? |
| Female | 17 | 2021 | 380317 | 0.05 | Why? |
| Zambia | 1 | 2020 | 401 | 0.05 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.05 | Why? |
| Cross Reactions | 2 | 2021 | 4374 | 0.05 | Why? |
| Estradiol | 1 | 2021 | 250 | 0.05 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.05 | Why? |
| Phagocytosis | 1 | 2021 | 409 | 0.05 | Why? |
| Antibody-Dependent Cell Cytotoxicity | 1 | 2021 | 349 | 0.05 | Why? |
| Placenta Diseases | 1 | 2021 | 180 | 0.05 | Why? |
| Male | 15 | 2021 | 367725 | 0.05 | Why? |
| Immunoenzyme Techniques | 1 | 2021 | 448 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 7 | 2021 | 37182 | 0.05 | Why? |
| Severity of Illness Index | 3 | 2021 | 48226 | 0.05 | Why? |
| Base Sequence | 1 | 2006 | 3581 | 0.04 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.04 | Why? |
| Models, Biological | 2 | 2020 | 4907 | 0.04 | Why? |
| Myeloid-Derived Suppressor Cells | 1 | 2021 | 316 | 0.04 | Why? |
| Fetal Blood | 1 | 2021 | 573 | 0.04 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.04 | Why? |
| Biodiversity | 1 | 2020 | 546 | 0.04 | Why? |
| Endemic Diseases | 1 | 2021 | 480 | 0.04 | Why? |
| Species Specificity | 1 | 2021 | 1356 | 0.04 | Why? |
| Myocardium | 1 | 2008 | 2323 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| ErbB Receptors | 1 | 2018 | 320 | 0.04 | Why? |
| Adult | 10 | 2021 | 244371 | 0.04 | Why? |
| Immunodominant Epitopes | 1 | 2021 | 813 | 0.04 | Why? |
| Young Adult | 6 | 2021 | 93724 | 0.04 | Why? |
| Interferon-beta | 1 | 2021 | 979 | 0.04 | Why? |
| HLA Antigens | 1 | 2021 | 830 | 0.04 | Why? |
| Survival Analysis | 1 | 2008 | 7592 | 0.04 | Why? |
| Complement Activation | 1 | 2021 | 949 | 0.03 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.03 | Why? |
| Kidney | 1 | 2008 | 3648 | 0.03 | Why? |
| Linear Models | 1 | 2020 | 1914 | 0.03 | Why? |
| Mitochondria | 1 | 2021 | 857 | 0.03 | Why? |
| Sex Factors | 2 | 2021 | 11014 | 0.03 | Why? |
| Immunoglobulin M | 2 | 2021 | 9091 | 0.03 | Why? |
| Mice, Knockout | 1 | 2018 | 1815 | 0.03 | Why? |
| Peru | 1 | 2017 | 1010 | 0.03 | Why? |
| Cohort Studies | 3 | 2021 | 36005 | 0.03 | Why? |
| United States Food and Drug Administration | 1 | 2020 | 1276 | 0.03 | Why? |
| Testosterone | 1 | 2018 | 596 | 0.03 | Why? |
| Aged | 7 | 2021 | 215776 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Sequence Analysis, RNA | 1 | 2021 | 2290 | 0.03 | Why? |
| Coronavirus | 1 | 2021 | 18339 | 0.03 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2021 | 1458 | 0.03 | Why? |
| Child, Preschool | 3 | 2021 | 36283 | 0.03 | Why? |
| Macaca mulatta | 1 | 2021 | 3716 | 0.03 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2021 | 2483 | 0.03 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.03 | Why? |
| Viral Load | 2 | 2021 | 15850 | 0.03 | Why? |
| Gene Expression | 1 | 2021 | 3332 | 0.03 | Why? |
| Whole Genome Sequencing | 1 | 2021 | 3239 | 0.03 | Why? |
| Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 7868 | 0.03 | Why? |
| Immunosuppressive Agents | 1 | 2008 | 6331 | 0.02 | Why? |
| Antibodies, Monoclonal | 2 | 2006 | 8041 | 0.02 | Why? |
| Hospitalization | 1 | 2020 | 54280 | 0.02 | Why? |
| Genotype | 1 | 2021 | 4697 | 0.02 | Why? |
| Lymphopenia | 1 | 2021 | 2669 | 0.02 | Why? |
| Pandemics | 6 | 2021 | 389249 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Rural Population | 1 | 2020 | 2408 | 0.02 | Why? |
| Immunity, Cellular | 1 | 2021 | 3614 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2018 | 5542 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Nuclear Localization Signals | 1 | 2005 | 85 | 0.02 | Why? |
| Infant | 2 | 2020 | 30274 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Precipitin Tests | 1 | 2005 | 40 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| African Americans | 1 | 2021 | 3363 | 0.02 | Why? |
| Recombinant Proteins | 2 | 2006 | 3786 | 0.02 | Why? |
| Microscopy, Fluorescence | 1 | 2006 | 335 | 0.02 | Why? |
| Virus Shedding | 1 | 2021 | 5834 | 0.02 | Why? |
| Sequence Analysis, Protein | 1 | 2005 | 309 | 0.02 | Why? |
| Blotting, Western | 1 | 2006 | 863 | 0.02 | Why? |
| Cross-Sectional Studies | 2 | 2021 | 53120 | 0.02 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.02 | Why? |
| Case-Control Studies | 1 | 2021 | 17671 | 0.01 | Why? |
| Mass Screening | 1 | 2021 | 8005 | 0.01 | Why? |
| Protein Structure, Secondary | 1 | 2005 | 1077 | 0.01 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.01 | Why? |
| Recombinant Fusion Proteins | 1 | 2005 | 919 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Mass Spectrometry | 1 | 2005 | 1165 | 0.01 | Why? |
| Pregnancy | 1 | 2021 | 23879 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Crystallography, X-Ray | 1 | 2005 | 2689 | 0.01 | Why? |
| Flow Cytometry | 1 | 2005 | 2393 | 0.01 | Why? |
| Risk Assessment | 1 | 2020 | 25439 | 0.01 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.01 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.01 | Why? |
| Mice, Inbred BALB C | 1 | 2005 | 5814 | 0.01 | Why? |
| United States | 1 | 2020 | 46150 | 0.01 | Why? |
| Child | 1 | 2020 | 70012 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2021 | 88759 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Mice | 1 | 2005 | 21357 | 0.00 | Why? |
Pekosz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(236)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(437)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_